ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,854.30
0.03%
S&P ASX All Technology
3,069.80
-0.26%
Brent Oil
82.195
-0.30%
US Dollar vs AUD
1.49901
-0.06%
Bitcoin
69,956.24
-0.25%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. PharmaCyte Biotech Inc (PMCB)

  7. PharmaCyte Biotech Inc (PMCB) News

PMCB

PharmaCyte Biotech (PMCB)

PharmaCyte Biotech Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PMCB
DateTimeSourceHeadlineSymbolCompany
21/05/202423:00Business WirePharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory DiseaseNASDAQ:PMCBPharmaCyte Biotech Inc
15/02/202407:38Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PMCBPharmaCyte Biotech Inc
07/02/202401:56Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PMCBPharmaCyte Biotech Inc
16/12/202309:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PMCBPharmaCyte Biotech Inc
29/11/202309:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
25/11/202308:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMCBPharmaCyte Biotech Inc
23/11/202309:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
23/11/202309:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
23/11/202309:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
23/11/202309:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
23/11/202309:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
23/11/202309:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
23/11/202308:00Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:PMCBPharmaCyte Biotech Inc
16/11/202300:30Business WirePharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.NASDAQ:PMCBPharmaCyte Biotech Inc
10/11/202309:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMCBPharmaCyte Biotech Inc
01/11/202300:15Business WirePharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box TechnologyNASDAQ:PMCBPharmaCyte Biotech Inc
01/11/202300:15Business WirePharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box TechnologyNASDAQ:PMCBPharmaCyte Biotech Inc
02/10/202315:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PMCBPharmaCyte Biotech Inc
22/09/202307:04Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:PMCBPharmaCyte Biotech Inc
18/09/202320:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PMCBPharmaCyte Biotech Inc
16/09/202307:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:PMCBPharmaCyte Biotech Inc
12/09/202311:56Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:PMCBPharmaCyte Biotech Inc
08/09/202306:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMCBPharmaCyte Biotech Inc
05/08/202306:40Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:PMCBPharmaCyte Biotech Inc
05/08/202306:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMCBPharmaCyte Biotech Inc
01/08/202307:18Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PMCBPharmaCyte Biotech Inc
01/08/202306:42Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PMCBPharmaCyte Biotech Inc
20/07/202300:28Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PMCBPharmaCyte Biotech Inc
17/06/202307:23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PMCBPharmaCyte Biotech Inc
16/06/202306:02Edgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)NASDAQ:PMCBPharmaCyte Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:PMCB

Your Recent History

NYSE
NKE
Nike
COIN
BTCUSD
Bitcoin
NASDAQ
MSFT
Microsoft
ASX
ANZ
Australia And New Zealan...
ASX
SUN
Suncorp
NYSE
KO
Coca Cola
ASX
ORG
Origin Energy
NYSE
DIS
Walt Disney
COIN
ETHUSD
Ethereum
NASDAQ
TSLA
Tesla
ASX
RIO
Rio Tinto
ASX
XFL
S&P ASX 50
ASX
NAB
National Australia Bank
NYSE
VZ
Verizon Communications
FX
GBPAUD
Sterling vs AUD
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved